➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Medtronic
Harvard Business School
McKinsey
Johnson and Johnson
Boehringer Ingelheim

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

VOLMAX Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

When do Volmax patents expire, and when can generic versions of Volmax launch?

Volmax is a drug marketed by Muro and is included in one NDA.

The generic ingredient in VOLMAX is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Thirty-nine suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

US ANDA Litigation and Generic Entry Outlook for Volmax

A generic version of VOLMAX was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.

  Start Trial

Summary for VOLMAX
Drug patent expirations by year for VOLMAX
Recent Clinical Trials for VOLMAX

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Merck Sharp & Dohme Corp.Phase 3

See all VOLMAX clinical trials

Paragraph IV (Patent) Challenges for VOLMAX
Tradename Dosage Ingredient NDA Submissiondate
VOLMAX TABLET, EXTENDED RELEASE;ORAL albuterol sulfate 019604

US Patents and Regulatory Information for VOLMAX

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-002 Dec 23, 1992 DISCN Yes No   Start Trial   Start Trial   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-001 Dec 23, 1992 DISCN Yes No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VOLMAX

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-001 Dec 23, 1992   Start Trial   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-002 Dec 23, 1992   Start Trial   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-002 Dec 23, 1992   Start Trial   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-001 Dec 23, 1992   Start Trial   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-001 Dec 23, 1992   Start Trial   Start Trial
Muro VOLMAX albuterol sulfate TABLET, EXTENDED RELEASE;ORAL 019604-002 Dec 23, 1992   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Medtronic
Mallinckrodt
Merck
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.